Photo - FAIR Biogen
63138

FAIR Biogen

United Kingdom
Market: Biotech
Stage of the project: Prototype or product is ready

Date of last change: 29.01.2025
Go to the owner's profile
2
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

We revolutionize beauty with proprietary biotech, scalable AI-driven innovation, and sustainable luxury, delivering disruptive, data-powered solutions like ISMYZ-5™ & TapTech™ for global impact.

Current Status

FAIR Biogen is in the early growth stage, with a fully developed and tested product portfolio powered by proprietary innovations like ISMYZ-5™ Complex, TapTech™, and SymbioTech™. Our MVP (Minimum Viable Product) has been validated through beta testing with exceptional results, and we are actively preparing for a go-to-market launch. Early partnerships and customer feedback loops have refined our strategy, positioning us for scalable commercialization and entry into key luxury retail, digital channels and licensing.

Problem or Opportunity

Beauty Problems:

Fragrance: Scent fades quickly, requiring frequent reapplication and 70% is lost to air.

Skincare: No one single product adapts to the skin’s shifting needs—leaving dryness, irritation, or inadequate protection unaddressed.

Makeup: Formulations don’t adapt to the skin resulting in uneven coverage, colour mismatch, and short-lived wear.

Solution (product or service)

FAIR Biogen Solutions:

Fragrance: Powered by AI driven cellular reprogramming, scent lasts up to 36 hours, nano-tech sensors enable reapplication directly from the skin, reducing evaporation to less than 5%.

Skincare: Biologically personalized all-in-one nano-tech solution, addressing aging, wrinkling, dryness, and irritation; delivering naturally radiant and revitalized skin.

Makeup: Adaptive nano-tech makeup solutions seamlessly sync with the skin to deliver a flawless finish whilst enhancing its natural radiance.

Business model

FAIR Biogen operates a hybrid business model designed for scalability, diversified revenue streams, and sustained growth. We have 3 core recurring revenue streams:

• Direct sales
• White label manufacturing
• Licensing fees

This tech-enabled, multi-channel approach positions FAIR Biogen to maximize revenue potential, capture market share, and scale globally while maintaining operational efficiency and profitability.
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility40
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Product Video
Presentation